NasdaqCM - Delayed Quote USD
Pasithea Therapeutics Corp. (KTTA)
At close: November 1 at 4:00 PM EDT
After hours: November 1 at 5:56 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder, MD & Executive Chairman | 250k | -- | 1948 |
| Dr. Tiago Reis Marques M.D., Ph.D. | CEO & Director | 480k | -- | 1977 |
| Mr. Daniel H. Schneiderman | Chief Financial Officer | 345.94k | -- | 1978 |
| Dr. Graeme Currie Ph.D. | Chief Development Officer | 346.62k | -- | 1967 |
| Dr. Yassine Bendiabdallah Ph.D. | COO & Head of UK Clinics | -- | -- | 1984 |
Pasithea Therapeutics Corp.
1111 Lincoln Road
Suite 500
Miami Beach, FL 33139
United States
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 8
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Corporate Governance
Pasithea Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 13, 2024 at 8:00 PM UTC
Pasithea Therapeutics Corp. Earnings Date
Recent Events
Related Tickers
ONCO Onconetix, Inc.
2.9000
+0.35%
SXTP 60 Degrees Pharmaceuticals, Inc.
0.7828
+1.53%
REVB Revelation Biosciences, Inc.
0.8230
-3.52%
DRMA Dermata Therapeutics, Inc.
1.2250
-3.54%
XRTX XORTX Therapeutics Inc.
1.4300
+1.06%
ZVSA ZyVersa Therapeutics, Inc.
1.9100
-4.98%
TOVX Theriva Biologics, Inc.
1.9900
+36.30%
QNRX Quoin Pharmaceuticals, Ltd.
0.7584
+1.51%
IMMX Immix Biopharma, Inc.
1.5900
-0.62%
AEON AEON Biopharma, Inc.
0.8799
-4.15%